New hope for mild stroke: catheter procedure could boost recovery

NCT ID NCT07390032

Not yet recruiting Disease control Sponsor: Feng Gao Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a procedure called endovascular recanalization—where doctors use a thin tube to remove or open a blocked artery in the brain—can improve recovery in people who have had a mild stroke. The trial will include 230 adults with a blocked basilar artery and mild symptoms. Half will receive the procedure plus standard care, and half will receive standard care alone. The main goal is to see if more people achieve a good recovery (able to live independently) at 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Endovascular recanalization (a procedure using catheters to remove or open blocked arteries in the brain)
What this could lead to
If successful, this could provide a better treatment option for people with mild strokes caused by a blocked basilar artery, potentially improving their recovery and reducing disability.
What could go wrong
This is a relatively early-stage trial with 230 participants, so results may not apply to everyone. The procedure carries risks like bleeding or vessel damage, and it may not prove more effective than standard medical therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MILD BASILAR ARTERY OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100070, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.